S&P 500   3,176.63 (+0.25%)
DOW   28,224.35 (+0.33%)
QQQ   207.58 (+0.52%)
AAPL   274.27 (+1.04%)
FB   194.09 (-1.35%)
MSFT   154.08 (+0.55%)
GOOGL   1,347.31 (-0.09%)
AMZN   1,763.30 (+0.17%)
NVDA   225.98 (+0.85%)
BABA   205.63 (+0.55%)
GE   11.49 (+0.44%)
TSLA   362.07 (+0.66%)
T   38.07 (-0.73%)
AMD   42.17 (-0.99%)
ACB   2.70 (+3.45%)
F   9.36 (+0.43%)
PRI   137.18 (+0.50%)
NFLX   300.69 (+0.75%)
BAC   34.85 (+0.46%)
GILD   66.47 (-1.72%)
DIS   147.03 (-0.49%)
S&P 500   3,176.63 (+0.25%)
DOW   28,224.35 (+0.33%)
QQQ   207.58 (+0.52%)
AAPL   274.27 (+1.04%)
FB   194.09 (-1.35%)
MSFT   154.08 (+0.55%)
GOOGL   1,347.31 (-0.09%)
AMZN   1,763.30 (+0.17%)
NVDA   225.98 (+0.85%)
BABA   205.63 (+0.55%)
GE   11.49 (+0.44%)
TSLA   362.07 (+0.66%)
T   38.07 (-0.73%)
AMD   42.17 (-0.99%)
ACB   2.70 (+3.45%)
F   9.36 (+0.43%)
PRI   137.18 (+0.50%)
NFLX   300.69 (+0.75%)
BAC   34.85 (+0.46%)
GILD   66.47 (-1.72%)
DIS   147.03 (-0.49%)
S&P 500   3,176.63 (+0.25%)
DOW   28,224.35 (+0.33%)
QQQ   207.58 (+0.52%)
AAPL   274.27 (+1.04%)
FB   194.09 (-1.35%)
MSFT   154.08 (+0.55%)
GOOGL   1,347.31 (-0.09%)
AMZN   1,763.30 (+0.17%)
NVDA   225.98 (+0.85%)
BABA   205.63 (+0.55%)
GE   11.49 (+0.44%)
TSLA   362.07 (+0.66%)
T   38.07 (-0.73%)
AMD   42.17 (-0.99%)
ACB   2.70 (+3.45%)
F   9.36 (+0.43%)
PRI   137.18 (+0.50%)
NFLX   300.69 (+0.75%)
BAC   34.85 (+0.46%)
GILD   66.47 (-1.72%)
DIS   147.03 (-0.49%)
S&P 500   3,176.63 (+0.25%)
DOW   28,224.35 (+0.33%)
QQQ   207.58 (+0.52%)
AAPL   274.27 (+1.04%)
FB   194.09 (-1.35%)
MSFT   154.08 (+0.55%)
GOOGL   1,347.31 (-0.09%)
AMZN   1,763.30 (+0.17%)
NVDA   225.98 (+0.85%)
BABA   205.63 (+0.55%)
GE   11.49 (+0.44%)
TSLA   362.07 (+0.66%)
T   38.07 (-0.73%)
AMD   42.17 (-0.99%)
ACB   2.70 (+3.45%)
F   9.36 (+0.43%)
PRI   137.18 (+0.50%)
NFLX   300.69 (+0.75%)
BAC   34.85 (+0.46%)
GILD   66.47 (-1.72%)
DIS   147.03 (-0.49%)
Log in

Cancer Genetics News Headlines (NASDAQ:CGIX)

$6.69
+0.01 (+0.15 %)
(As of 12/13/2019 10:24 AM ET)
Today's Range
$6.62
Now: $6.69
$6.85
50-Day Range
$0.11
MA: $4.44
$8.81
52-Week Range
$2.00
Now: $6.69
$20.70
Volume39,069 shs
Average Volume1.75 million shs
Market Capitalization$14.05 million
P/E RatioN/A
Dividend YieldN/A
Beta2.41

Headlines

Cancer Genetics (NASDAQ CGIX) News Headlines

Source:
DateHeadline
Cancer Genetics Inc (NASDAQ:CGIX) Short Interest Up 78.1% in NovemberCancer Genetics Inc (NASDAQ:CGIX) Short Interest Up 78.1% in November
www.americanbankingnews.com - December 11 at 9:24 PM
Cancer Genetics Inc (NASDAQ:CGIX) Short Interest UpdateCancer Genetics Inc (NASDAQ:CGIX) Short Interest Update
www.americanbankingnews.com - November 26 at 5:36 PM
Cancer Genetics up big on improved improved Q3 resultsCancer Genetics up big on improved improved Q3 results
seekingalpha.com - November 20 at 2:14 PM
Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business UpdateCancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
finance.yahoo.com - November 20 at 9:14 AM
Introducing Cancer Genetics (NASDAQ:CGIX), The Stock That Collapsed 98%Introducing Cancer Genetics (NASDAQ:CGIX), The Stock That Collapsed 98%
finance.yahoo.com - November 14 at 9:50 AM
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial ResultsInterpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
www.benzinga.com - November 13 at 6:46 PM
Cancer Genetics Announces 1-for-30 Reverse Stock SplitCancer Genetics Announces 1-for-30 Reverse Stock Split
finance.yahoo.com - October 24 at 1:22 PM
Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business UpdateCancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update
finance.yahoo.com - August 20 at 11:02 AM
Interpace up 9% after hours on Cancer Genetics dealInterpace up 9% after hours on Cancer Genetics deal
seekingalpha.com - July 15 at 7:06 PM
Cancer Genetics, Inc. Announces Strategic TransactionsCancer Genetics, Inc. Announces Strategic Transactions
finance.yahoo.com - July 15 at 7:06 PM
Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial OfficerInnovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer
finance.yahoo.com - June 24 at 3:57 PM
LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO SpaceLabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space
finance.yahoo.com - June 5 at 8:14 AM
Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business UpdateCancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update
www.nasdaq.com - May 21 at 6:21 AM
Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business UpdatesCancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates
finance.yahoo.com - April 16 at 8:24 AM
Cancer Genetics: 4Q Earnings SnapshotCancer Genetics: 4Q Earnings Snapshot
finance.yahoo.com - April 16 at 8:24 AM
Investors Who Bought Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Are Now Down 98%Investors Who Bought Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Are Now Down 98%
finance.yahoo.com - March 26 at 7:48 PM
Cancer Genetics, Inc. Estimate MomentumCancer Genetics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:05 PM
Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful?Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 14 at 6:28 PM
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock - GlobeNewswireCancer Genetics, Inc. Announces Closing of Public Offering of Common Stock - GlobeNewswire
globenewswire.com - February 1 at 8:19 AM
Cancer Genetics Inc.Cancer Genetics Inc.
www.barrons.com - January 31 at 8:11 AM
Mid-Afternoon Market Update: Sanmina Jumps On Upbeat Earnings; Cancer Genetics Shares SlideMid-Afternoon Market Update: Sanmina Jumps On Upbeat Earnings; Cancer Genetics Shares Slide
www.benzinga.com - January 29 at 6:18 PM
Cancer Genetics announces pricing of common stock, Shares down 15.7%Cancer Genetics announces pricing of common stock, Shares down 15.7%
seekingalpha.com - January 29 at 8:10 AM
Cancer Genetics down 16% premarket on stock offeringCancer Genetics down 16% premarket on stock offering
seekingalpha.com - January 29 at 8:10 AM
Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common StockCancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock
finance.yahoo.com - January 29 at 8:10 AM
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswireCancer Genetics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
globenewswire.com - January 28 at 6:25 PM
Insider Buys Of The Week: Cancer Genetics, Dish Network, Valvoline - BenzingaInsider Buys Of The Week: Cancer Genetics, Dish Network, Valvoline - Benzinga
www.benzinga.com - January 21 at 6:03 PM
Cancer Genetics +16% on loan forbearance dealCancer Genetics +16% on loan forbearance deal
seekingalpha.com - January 17 at 8:14 AM
Cancer Genetics, Inc. Announces Closing of Public Offering of Common StockCancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
finance.yahoo.com - January 14 at 6:11 PM
Cancer Genetics down 28% on pricing equity offeringCancer Genetics down 28% on pricing equity offering
seekingalpha.com - January 10 at 8:17 AM
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common StockCancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 10 at 8:16 AM
Cancer Genetics readies stock offering; shares down 6% after hoursCancer Genetics readies stock offering; shares down 6% after hours
seekingalpha.com - January 9 at 7:05 PM
Cancer Genetics, Inc. Announces Proposed Public Offering of Common StockCancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 9 at 7:05 PM
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma ServicesCancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
finance.yahoo.com - January 9 at 8:23 AM
Cancer Genetics (CGIX) Terminates Proposed Merger with NovellusDxCancer Genetics (CGIX) Terminates Proposed Merger with NovellusDx
www.streetinsider.com - December 17 at 5:47 PM
Cancer Genetics Terminates Proposed Merger with NovellusDxCancer Genetics Terminates Proposed Merger with NovellusDx
finance.yahoo.com - December 17 at 8:12 AM
Todays Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer GeneticsToday's Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer Genetics
finance.yahoo.com - December 14 at 8:15 AM
Cancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue EstimatesCancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 20 at 8:14 AM
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business UpdatesCancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
finance.yahoo.com - November 19 at 5:25 PM
Cancer Genetics: 3Q Earnings SnapshotCancer Genetics: 3Q Earnings Snapshot
finance.yahoo.com - November 19 at 5:25 PM
Form 425 CANCER GENETICS, INC Filed by: CANCER GENETICS, INCForm 425 CANCER GENETICS, INC Filed by: CANCER GENETICS, INC
www.streetinsider.com - November 16 at 6:01 PM
Cancer Genetics (CGIX) Appoints Glenn Miles as Chief Financial OfficerCancer Genetics (CGIX) Appoints Glenn Miles as Chief Financial Officer
www.streetinsider.com - November 15 at 8:15 AM
Cancer Genetics Appoints Glenn Miles as Chief Financial OfficerCancer Genetics Appoints Glenn Miles as Chief Financial Officer
finance.yahoo.com - November 14 at 5:24 PM
Myriad Presents Two New Studies at the Western Section of the American Urological AssociationMyriad Presents Two New Studies at the Western Section of the American Urological Association
www.nasdaq.com - November 2 at 8:10 AM
Will Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should KnowWill Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - November 1 at 6:10 PM
Cancer Genetics Issues Letter to ShareholdersCancer Genetics Issues Letter to Shareholders
finance.yahoo.com - October 16 at 8:18 AM
Cancer Genetics up 16% on collaborating with Cellaria for precision medicine toolsCancer Genetics up 16% on collaborating with Cellaria for precision medicine tools
seekingalpha.com - October 8 at 4:51 PM
Global Genetic Testing Market to Witness a CAGR of 12.2% during 2018-2024Global Genetic Testing Market to Witness a CAGR of 12.2% during 2018-2024
globenewswire.com - October 8 at 8:11 AM
Cancer Genetics and Cellaria Partner on Precision Medicine ToolsCancer Genetics and Cellaria Partner on Precision Medicine Tools
finance.yahoo.com - October 8 at 8:11 AM
Robbins Arroyo LLP: Cancer Genetics, Inc. (CGIX) Sued by Shareholders in Recently Filed Class ActionRobbins Arroyo LLP: Cancer Genetics, Inc. (CGIX) Sued by Shareholders in Recently Filed Class Action
finance.yahoo.com - September 29 at 8:09 AM
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical TrialsCancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
finance.yahoo.com - September 20 at 4:57 PM
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel